18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer’s Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis-Reference-Cited by-同舟云学术

18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer’s Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis

Published:2019-08-20 Issue:4 Volume:70 Page:1197-1207
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Khosravi Mohsen¹,Peter Jonah²,Wintering Nancy A.³,Serruya Mijail⁴,Shamchi Sara Pourhassan²,Werner Thomas J.²,Alavi Abass²,Newberg Andrew B.¹³

Affiliation:

1. Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA

2. Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA

3. Marcus Institute of Integrative Health, Thomas Jefferson University, Philadelphia, PA, USA

4. Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference67 articles.

1. Deaths from Alzheimer’s Disease - United States, 1999-2014;Taylor;MMWR Morb Mortal Wkly Rep,2017

2. 2017 Alzheimer’s disease facts and figures;Alzheimer’s Association;Alzheimers Dement,2017

3. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank;Barker;Alzheimer Dis Assoc Disord,2002

4. The natural history of cognitive decline in Alzheimer’s disease;Wilson;Psychol Aging,2012

5. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease;McKhann;Neurology,1984

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral glucose metabolism in Alzheimer's disease;Cortex;2024-10

2. The Association Between Brain Metabolic Biomarkers Using 18F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2024-09-05

3. Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit;Ageing Research Reviews;2024-08

4. Efficacy and Safety of Exogenous Ketones in People with Mild Neurocognitive Disorder and Alzheimer’s Disease: A Systematic Literature Review;Nutrition Reviews;2024-07-24

5. Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using ¹⁸F‐FDG PET/MRI Radiomics;CNS Neuroscience & Therapeutics;2023-11-30